- Home
- FEMY
FEMY
Femasys Inc.
as 04-18-2025 1:36pm EST
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | SUWANEE |
| Market Cap: | N/A | IPO Year: | 2021 |
| Target Price: | $11.50 | AVG Volume (30 days): | 312.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.85 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.86 - $1.80 | Next Earning Date: | 05-08-2025 |
| Revenue: | $1,629,108 | Revenue Growth: | 51.97% |
| Revenue Growth (this year): | 441.89% | Revenue Growth (next year): | 101.29% |
Latest Femasys Inc. News
FEMY Breaking Stock News: Dive into FEMY Ticker-Specific Updates for Smart Investing
Zacks
23 days ago
Femasys Inc. (FEMY) Reports Q4 Loss, Lags Revenue Estimates
GlobeNewswire
23 days ago
Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update
TipRanks
a month ago
Femasys price target raised to $15 from $12 at H.C. Wainwright
GlobeNewswire
a month ago
Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations
ACCESS Newswire
a month ago
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
MT Newswires
a month ago
Femasys Signs FemBloc Commercial Distribution Deals
GlobeNewswire
a month ago
Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain
GlobeNewswire
a month ago
Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach
Compare FEMY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FEMY Femasys Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.